191 related articles for article (PubMed ID: 2891137)
21. Turnover and storage of newly synthesized adenine nucleotides in bovine adrenal medullary cell cultures.
Corcoran JJ; Wilson SP; Kirshner N
J Neurochem; 1986 Jan; 46(1):151-60. PubMed ID: 3940276
[TBL] [Abstract][Full Text] [Related]
22. Interactions of 1-methyl-4-phenylpyridinium and other compounds with P-glycoprotein: relevance to toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Staal RG; Yang JM; Hait WN; Sonsalla PK
Brain Res; 2001 Aug; 910(1-2):116-25. PubMed ID: 11489261
[TBL] [Abstract][Full Text] [Related]
23. Ascorbic acid and catecholamine release from digitonin-treated chromaffin cells.
Morita K; Levine M; Heldman E; Pollard HB
J Biol Chem; 1985 Dec; 260(28):15112-6. PubMed ID: 4066665
[TBL] [Abstract][Full Text] [Related]
24. Toxic effects of potential environmental neurotoxins related to 1-methyl-4-phenylpyridinium on cultured rat dopaminergic neurons.
Michel PP; Dandapani BK; Sanchez-Ramos J; Efange S; Pressman BC; Hefti F
J Pharmacol Exp Ther; 1989 Feb; 248(2):842-50. PubMed ID: 2783974
[TBL] [Abstract][Full Text] [Related]
25. A model of chronic neurotoxicity: long-term retention of the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) within catecholaminergic neurons.
Johannessen JN
Neurotoxicology; 1991; 12(2):285-302. PubMed ID: 1956587
[TBL] [Abstract][Full Text] [Related]
26. Nicotine stimulates secretion of both catecholamines and acetylcholinesterase from cultured adrenal chromaffin cells.
Mizobe F; Livett BG
J Neurosci; 1983 Apr; 3(4):871-6. PubMed ID: 6834109
[TBL] [Abstract][Full Text] [Related]
27. Subcellular distribution of ascorbate in bovine adrenal medulla. Evidence for accumulation in chromaffin granules against a concentration gradient.
Ingebretsen OC; Terland O; Flatmark T
Biochim Biophys Acta; 1980 Mar; 628(2):182-9. PubMed ID: 7357036
[TBL] [Abstract][Full Text] [Related]
28. Catecholamines are present in a synaptic-like microvesicle-enriched fraction from bovine adrenal medulla.
Annaert WG; Llona I; Backer AC; Jacob WA; De Potter WP
J Neurochem; 1993 May; 60(5):1746-54. PubMed ID: 8473893
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of the neurotoxicity of 1-methyl-4-phenylpyridinium (MPP+), the toxic bioactivation product of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Singer TP; Ramsay RR; McKeown K; Trevor A; Castagnoli NE
Toxicology; 1988 Apr; 49(1):17-23. PubMed ID: 3287690
[TBL] [Abstract][Full Text] [Related]
30. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. II. Susceptibility among mammalian species correlates with the toxin's metabolic patterns in brain microvessels and liver.
Riachi NJ; Harik SI; Kalaria RN; Sayre LM
J Pharmacol Exp Ther; 1988 Feb; 244(2):443-8. PubMed ID: 3258032
[TBL] [Abstract][Full Text] [Related]
31. Regulation of the chromaffin granule catecholamine transporter in cultured bovine adrenal medullary cells: stimulus-biosynthesis coupling.
Desnos C; Laran MP; Scherman D
J Neurochem; 1992 Dec; 59(6):2105-12. PubMed ID: 1279122
[TBL] [Abstract][Full Text] [Related]
32. Secretion of newly taken up ascorbic acid by adrenomedullary chromaffin cells originates from a compartment different from the catecholamine storage vesicle.
Daniels AJ; Dean G; Viveros OH; Diliberto EJ
Mol Pharmacol; 1983 Mar; 23(2):437-44. PubMed ID: 6835202
[TBL] [Abstract][Full Text] [Related]
33. Co-release of enkephalin and catecholamines from cultured adrenal chromaffin cells.
Livett BG; Dean DM; Whelan LG; Udenfriend S; Rossier J
Nature; 1981 Jan; 289(5795):317-9. PubMed ID: 7453829
[TBL] [Abstract][Full Text] [Related]
34. Toxicity of the 1-methyl-4-phenyl-2,3-dihydropyridinium and 1-methyl-4-phenylpyridinium species in primary cultures of mouse astrocytes.
Wu EY; Langston JW; Di Monte DA
J Pharmacol Exp Ther; 1992 Jul; 262(1):225-30. PubMed ID: 1625201
[TBL] [Abstract][Full Text] [Related]
35. The neurotoxins 1-methyl-4-phenylpyridinium and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine are substrates for the organic cation transporter in renal brush border membrane vesicles.
Sokol PP; Holohan PD; Ross CR
J Pharmacol Exp Ther; 1987 Jul; 242(1):152-7. PubMed ID: 2956410
[TBL] [Abstract][Full Text] [Related]
36. Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine.
Kindt MV; Heikkila RE; Nicklas WJ
J Pharmacol Exp Ther; 1987 Sep; 242(3):858-63. PubMed ID: 3498818
[TBL] [Abstract][Full Text] [Related]
37. Effect of 1-methyl-4-phenylpyridinium ion (MPP+) on catecholamine levels and activity of related enzymes in clonal rat pheochromocytoma PC12h cells.
Naoi M; Takahashi T; Nagatsu T
Life Sci; 1988; 43(18):1485-91. PubMed ID: 2903426
[TBL] [Abstract][Full Text] [Related]
38. A dopaminergic cell line variant resistant to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Denton T; Howard BD
J Neurochem; 1987 Aug; 49(2):622-30. PubMed ID: 3496426
[TBL] [Abstract][Full Text] [Related]
39. Selective MPP+ uptake into synaptic dopamine vesicles: possible involvement in MPTP neurotoxicity.
Del Zompo M; Piccardi MP; Ruiu S; Quartu M; Gessa GL; Vaccari A
Br J Pharmacol; 1993 Jun; 109(2):411-4. PubMed ID: 8102929
[TBL] [Abstract][Full Text] [Related]
40. Selective destruction of cultured dopaminergic neurons from fetal rat mesencephalon by 1-methyl-4-phenylpyridinium: cytochemical and morphological evidence.
Sanchez-Ramos JR; Michel P; Weiner WJ; Hefti F
J Neurochem; 1988 Jun; 50(6):1934-44. PubMed ID: 2897430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
